Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

That includes continuous glucose monitoring systems developed by Lilly's partner Dexcom as well as other manufacturers, as well as wearable devices from Fitbit, Garmin, Google and Apple.

Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division. The deal will see Dexcom's continuous glucose monitors integrated into ...

Shares of medical-device makers ResMed Inc. and Inspire Medical Systems Inc. tumbled on Monday after Eli Lilly & Co. said it has applied for regulatory approval of its weight-loss drug Zepbound to ...

Eli Lilly & Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative to injections.

Lilly noted that the FDA decision came following ... disruptions on patients not on a positive airway pressure (PAP) device that helps them when sleeping. ResMed Chief Medical Officer Carlos ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.